GammaAminobutyric Acid Receptor Subunit Gamma
Market
Gamma-Aminobutyric Acid Receptor Subunit
Gamma 2 Market Scope: Industry Analysis, Market
Size, Growth, Trends Till 2031
Request Sample Report
2
Gamma-Aminobutyric Acid Receptor Subunit Gamma 2
Market Size and Growth
The Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market is witnessing significant growth, driven by increasing demand for neuropharmaceuticals and advancements in neurological disorder treatments. The market size was valued at approximately $XX million in 2023, with projections indicating a robust compound annual growth rate (CAGR) over the next five years, reflecting expanding research and development efforts.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Jiangsu Hengrui Medicine Co Ltd
◍ Jiangsu Nhwa Pharmaceutical Corp Ltd
◍ Paion AG
◍ Pfizer Inc
◍ Primex Pharmaceuticals Oy
◍ Takeda
The Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market involves companies like Jiangsu Hengrui, Jiangsu Nhwa, Paion, Pfizer, Primex, and Takeda, focusing on developing therapeutics targeting GABA receptors. These firms enhance market growth through innovative drug development, partnerships, and expanding treatment options for neurological disorders. Sales figures vary per company, reflecting their market influence.
Request Sample Report
Market Segmentation
By Application By Product
Insomnia ◍ Hypertension
Others
Others ◍ General Anesthetic Effect
◍ EL-001 ◍ LASSBio-785
LASSBio-786
Midazolam Hydrochloride
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
